Clinical trial
Low-dose Growth Hormone for the Treatment of Gastroparesis
NCT06803589 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Low-dose Growth Hormone for the Treatment of Gastroparesis
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- October 22, 2024
- Completion date
- December 31, 2027
- Enrollment
- 10 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.